News › Clinical Practice, Industry News, Patient Care

Candela Announces Health Canada Approval of New Gynecological Indications for CO2RE Laser Platform

June 18, 2020

Candela Corporation, a leading global aesthetic device company, has announced that Health Canada has approved the CO2RE laser, the world’s first fully integrated CO2 workstation, for the treatment of genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) in adult women.
The CO2RE laser, a single CO2 platform equipped with six treatment modes and multiple customized handpieces, is indicated for use in 10 medical specialties, including dermatology, aesthetics and gynecology. The CO2RE laser with Intima handpiece and module provides practitioners a simple and efficient gynecological solution for the treatment of the introitus, vaginal canal and external genitalia.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s
    • Allergan Aesthetics Debuts AA Signature in the United States with SKIN360
    • Candela Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • FDA Approves Additional Warning for Kybella Labeling
    • Federal Bill Would Establish New Ownership and Management Requirements for Medical Practices
Advertisement